Neuroendocrine Tumors trials recruiting in Maryland

All Neuroendocrine Tumors trials nationally

Cities in Maryland

Recruiting trials in Maryland

• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
  NCT03412877 · Phase: Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · Maryland: Bethesda
• Integrated Cancer Repository for Cancer Research
  NCT02012699 · Phase: Not specified · Ages: 19 Years to 110 Years · Sex: All (male and female) · Maryland: Randallstown, Westminster
• Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
  NCT03206060 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda
• Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
  NCT04074135 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · Maryland: Bethesda
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
  NCT03452774 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Maryland: Baltimore, Bethesda, Silver Spring, Towson
• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
  NCT05477576 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Glen Burnie